Cannell & Co. Biodesix Inc Call Options Transaction History
Cannell & Co.
- $3.01 Billion
- Q4 2023
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BDSX
# of Institutions
10Shares Held
1.14MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY416KShares$3.33 Million0.0% of portfolio
-
Birchview Capital, LP Burlington, VT287KShares$2.29 Million1.72% of portfolio
-
Allworth Financial LP99.3KShares$794,6480.0% of portfolio
-
Ajo Vista, LLC Boston, MA45.1KShares$360,9920.35% of portfolio
-
Cvi Holdings, LLC Wilmington, DE38.5KShares$308,2800.51% of portfolio
About BIODESIX INC
- Ticker BDSX
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 39,982,000
- Market Cap $320M
- Description
- Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...